Evidence map›Paper›PMID 25015358›Full record

ArticleInvestigative ophthalmology & visual science2014

Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis.

Venu Talla, Vittorio Porciatti, Vince Chiodo, Sanford L Boye, William W Hauswirth, John Guy

Open access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Mitochondrial function in development and disease.Disease models & mechanisms · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Venu TallaBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, Miller School of Medicine, Miami, Florida, United States.
Vittorio PorciattiBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, Miller School of Medicine, Miami, Florida, United States.
Vince ChiodoDepartment of Ophthalmology, University of Florida, Gainesville, Florida, United States.
Sanford L BoyeDepartment of Ophthalmology, University of Florida, Gainesville, Florida, United States.
William W HauswirthDepartment of Ophthalmology, University of Florida, Gainesville, Florida, United States.
John GuyBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, Miller School of Medicine, Miami, Florida, United States.
University of Florida · USUniversity of Miami · US

Funding

Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
Transgenic Mitomice Models for Treatment of Blinding DiseasesR01EY012355 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GUY, JOHN · 1999 to 2016
$3.4M
Modification of AdenoAssociated Virus to Deliver DNA Directly to MitochondriaR01EY017141 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI YU, HONG · 2007 to 2019
$3.4M
ANTIOXIDANT SYSTEMS AND AGE RELATED MACULAR DEGENERATIONR01EY007892 · NEI · VANDERBILT UNIVERSITY · PI STERNBERG, PAUL · 1994 to 2010
$3.0M
Vision Research CoreP30EY021721 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 2011 to 2015
$2.8M
RETINAL GANGLION CELL PLASTICITY IN GLAUCOMAR01EY019077 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PORCIATTI, VITTORIO · 2009 to 2015
$2.1M
NEI NIH HHS EY012355NEI NIH HHS EY017141NEI NIH HHS EY019077NEI NIH HHS EY021721NEI NIH HHS P30 EY014801NEI NIH HHS P30-EY014801NEI NIH HHS P30 EY021721NEI NIH HHS R01 EY007892NEI NIH HHS R01 EY012355NEI NIH HHS R01 EY017141NEI NIH HHS R01 EY019077NEI NIH HHS R01EY07892
6 · The paper itself

Abstract

purposeTo rescue visual loss and optic neuropathy in experimental autoimmune encephalomyelitis (EAE).

methodsEncephalomyelitis was induced in mice that received intravitreal injections of AAV2-mtHSP70Flag or AAV2-Cox8-mCherry. Additional mice were injected with AAV2-Cox8-mCherry, but not sensitized for EAE. Visual function was assessed by pattern electroretinograms (PERG) at 1, 3, and 6 months post injection (MPI). Optical coherence tomography (OCT) evaluated the thickness of the inner plexiform layer + nerve fiber layers at 1, 3, and 6 MPI. Retinas and optic nerves (ONs) of mice euthanized 6 MPI were processed for light and electron microscopy. Expression of mtHSP70Flag in the retina and ONs was evaluated by RT-PCR, immunofluorescence, and Western blotting. The activities of respiratory complexes I and III, as well as mitochondrial protein import were quantitated.

resultsExpression: immunofluorescence revealed punctate and perinuclear expression of mtHSP70Flag that colocalized with mitochondrial porin in thy1.2 labeled retinal ganglion cells (RGCs). Immunoblotting and RT-PCR confirmed mtHSP70Flag expression in the retina and ON. Rescue: treatment with mtHSP70Flag resulted in a 44% increase in PERG amplitude and less delays in latency relative to the EAE-mCherry group that also showed progressive inner retinal thinning. At 6 MPI, the almost 50% loss of RGCs and optic nerve axons in EAE mice was suppressed by mtHSP70Flag. In addition, retinas of EAE-mtHSP70Flag mice showed nearly complete rescue of complex I and III activities that was reduced by one-third in the EAE-mCherry retinas. Lastly, reductions in import of COX8-mCherry into mitochondria of mice sensitized for EAE improved by 30% with mtHSP70Flag gene therapy.

conclusionsMitochondrial HSP70 ameliorates mitochondrial dysfunction that culminates in irreversible visual loss and atrophy of the optic nerve in EAE suggesting that it may be useful to prevent irreversible disability in patients with optic neuritis and multiple sclerosis (MS).

Indexed as

AnimalsBlindnessElectroretinographyEncephalomyelitis, Autoimmune, ExperimentalFemaleGenetic TherapyHSP70 Heat-Shock ProteinsMiceMitochondriaMitochondrial ProteinsOptic AtrophyOptic NerveRetinaRetinal Ganglion CellsHSP70 Heat-Shock ProteinsMitochondrial Proteinsgene therapymtHSP70optic neuropathy

Identifiers

PMID25015358
PMCPMC4139113
OpenAlexW2005865625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.